tirzepatide discontinuation Reasons for of Obesity Pharmacotherapy With Semaglutide or in Clinical Practice Procedure Helps Prevent Weight Regain

Safety, Side Effects, and Medical Supervision Both sermorelin and tirzepatide are generally well-tolerated, though mild side effects such as nausea, injection site reactions, and fatigue may occur during dose escalation

De Velasco MA et al

Unopened vials typically retain stability for 2436 months from manufacture, while opened pens lose efficacy after 28 days at room temperature or up to 56 days refrigerated, depending on formulation

Olsen, E

Rossi et al

Realistic Weight Loss Expectations During Your First Year Most people experience noticeable appetite reduction and early weight loss within the first 24 weeks of starting semaglutide, though weight change on a scale may lag behind reduced food intake by a few weeks